ZYAK
Latest round
- Series A
Last raised
- Jul 2019
Total raised
- $36M
Investors
- 7
About ZYAK
Established in 2001 and based in Tianjin, China, ZYAK is a vaccine developer and manufacturer. It has acquired High-Tech Enterprise Certificate. The company is mainly engaged in the research and development, production and sales of human vaccines. Its products include influenza virus subunit vaccines, etc. The company generates revenue by developing human vaccine such as Influenza virus subunit vaccine.
Who invested in ZYAK
7 investors across 1 round
See all investors in ZYAK
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 4, 2019
Amount
$36M
Investors
Questions about ZYAK
Who invested in ZYAK?
ZYAK has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ZYAK raised?
ZYAK has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ZYAK last raise money?
ZYAK's most recent round on record is a Series A, in Jul 2019.
What does ZYAK do?
Established in 2001 and based in Tianjin, China, ZYAK is a vaccine developer and manufacturer.
Where is ZYAK headquartered?
ZYAK is headquartered in Tianjin, China.
Which VCs invest in companies like ZYAK?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at ZYAK's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like ZYAK? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.